| [1] |
Zhao Weihua, Xu Haiping, Peng Zhigang, Yao Yibing, Jiang Yanfeng, Ma Jie.
Clinical prognostic analysis on 69 cases of adult Hodgkin lymphoma
[J]. Clinical Focus, 2016, 31(1): 59-62.
|
| [2] |
Zhang Jiqing;Zhong Lei;Li Jine.
Role of arsenic trioxide induced apoptosis in Burkitt lymphoma cell line Raji and influence on C-myc expression
[J]. Clinical Focus, 2015, 30(10): 1123-1126.
|
| [3] |
WEI An-wei;YUE Ya-guang;CHEN Guang-xia;JIANG Kui;WANG Bang-mao;ZHOU Lu;XU Dong-bo.
Significance of interleukin 17 and interleukin 8 in gastric mucosa-associated lymphoid tissue lymphoma
[J]. CLINICAL FOCUS, 2013, 28(11): 1246-0.
|
| [4] |
DU Hong-yu;ZHANG Su-xian;ZHOU Min.
Risk factors of nosocomial lung infections in B-cell lymphoma patients who were treated by "rituximab+CHOP" chemotherapy program
[J]. CLINICAL FOCUS, 2013, 28(3): 258-260.
|
| [5] |
.
[J]. Clinical Focus, 2012, 27(21): 1915-1916.
|
| [6] |
.
[J]. Clinical Focus, 2012, 27(20): 1814-1815.
|
| [7] |
.
[J]. Clinical Focus, 2012, 27(18): 1619-0.
|
| [8] |
SUN Guan-xing;CAO Xiang-shan;LI Qing.
Expression and clinical significance of BCL-6 and BCL-2 in diffuse large B-cell lymphoma
[J]. Clinical Focus, 2012, 27(8): 652-656.
|
| [9] |
.
[J]. Clinical Focus, 2012, 27(7): 621-623.
|
| [10] |
WU Xin;CHEN Gang;SUN Ke-kang;LING Chun-hua;LIU Wei;CHEN Yan-bin;HUANG ban-an;JI Cheng.
Analysis on 9 cases of primary pulmonary lymphoma and literature review
[J]. CLINICAL FOCUS, 2011, 26(20): 1771-0.
|
| [11] |
HAN Li-jie;ZHAO Xiao-wu;DONG Xiu-juan;XIA Dong-cai.
Effect and cardiotoxicity of CTOP and CHOP in treatment of non-Hodgkin lymphoma
[J]. CLINICAL FOCUS, 2011, 26(3): 208-211.
|
| [12] |
CHEN Jie;TIAN Hong;WU Ying.
Effect and tolerance of alternating triple therapy in older patients with peripheral T cell lymphoma
[J]. CLINICAL FOCUS, 2011, 26(2): 100-103.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2010, 25(24): 2180-2180.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2010, 25(18): 1639-0.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2010, 25(17): 1510-0.
|
